Article
In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation.
Scientific reports - 10 Jun 2020
Krupar Rosemarie, Watermann Christian, Idel Christian, Ribbat-Idel Julika, Offermann Anne, Pasternack Helen, Kirfel Jutta, Sikora Andrew G, Perner Sven
Abstract excerpt
The tumor immune microenvironment (TIME) of head and neck squamous cell carcinomas (HNSCC) and other solid malignancies is a key determinant of therapy response and prognosis. Among other factors, it is shaped by the tumor mutational burden and defects in DNA repair enzymes. Based on the TCGA database we aimed to define specific, altered genes associated with different TIME types, which might represent new...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.